Wall Street News Alert: Investment Alert: ELHI! February 20, 2008

Market Wire, February, 2008

Wall Street News Alert's "stocks to watch" this morning are: Edgeline Holdings, Inc. (OTCBB: ELHI), MannKind Corporation (NASDAQ: MNKD), Holly Corporation (NYSE: HOC) and Schering-Plough Corporation (NYSE: SGP).

Having just announced one of its research programs for which it has rights was awarded a peer reviewed National Institute Of Health Grant for $179,000, Edgeline Holdings, Inc. (OTCBB: ELHI), which recently announced a name change to Oncolin Therapeutics Inc., is a "must see" for investors. Yesterday after the markets closed, the company issued a press release announcing that it has agreed to the terms of a license for a key patent that involves the synthesis of 2-deoxy sugars and their derivatives.

This is more great news for the company and its investors! This enabling patent provides processes to synthesize compounds that would otherwise be difficult and expensive to prepare with high purity and steroselectivity. These compounds are the lead drugs in the company's antimetabolite development program focused on the treatment of cancers, especially brain tumors.

"This program is currently being developed to initiate human clinical trials and therefore having a cost effective synthesis to the compounds is an important advantage for the timely development of these drugs," said Dr Donald Picker, COO of Edgeline Holdings, Inc.

Dr. Donald Picker first came to the attention of Wall Street News Alert on January 8, 2008 when it was announced in a company press release that he had joined Intertech Bio. This was a great move for the company. Dr. Picker and his group were responsible for the development of Carboplatin, one of the world's leading cancer drugs currently in use with annual sales of over $500 million.

Wall Street News Alert is continuing to alert investors to monitor the progress of the company! Last week the company reported that one of its research programs for which it has rights was awarded a peer reviewed National Institute Of Health Grant for $179,000 to support research on thermally targeted delivery of Doxorubicin. "We are very happy that this program has received funding from such a prestigious organization as the NIH to help progress this potential platform technology," commented Dr. Donald Picker.

In other recent news: Edgeline Holdings, Inc. has recently announced it has obtained an exclusive option agreement with The University of Texas M.D. Anderson Cancer Center which provides the Company the right to negotiate a license for five technologies relating to the treatment of various cancers over a nine month period.

In addition, Edgeline Holdings, Inc. has recently announced a Joint Development Agreement with Houston Pharmaceuticals to assist the Company in obtaining a license for certain patents, several of which are from the University of Mississippi and the University of Louisiana. Houston Pharmaceutical will continue collaborations with both universities and assist them in securing grants on behalf of the company.

Prior to the latest press release, the stock closed Tuesday at Forty Three cents a share.

For an in-depth profile of Edgeline Holdings, visit http://www.WallStreetNewsAlert.com/HotStocks/ELHI021908/default.aspx .

MannKind Corporation (NASDAQ: MNKD) down 0.6% on 218,000 shares traded.

MannKind Corporation focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer.

Holly Corporation (NYSE: HOC) up 12.2% on 2.7 million shares traded.

Holly Corporation, headquartered in Dallas, Texas, is an independent petroleum refiner and marketer that produces high value light products such as gasoline, diesel fuel and jet fuel.

Schering-Plough Corporation (NYSE: SGP) up 0.4% on 9.6 million shares traded.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world.

Market Commentary:

"Improving slightly for the second straight month, the National Association of Home Builders said its index measuring homebuilder confidence inched up in February, rising to 20 from 19 in January. However, Wall Street remains wary about the prospects for the housing market," stated Sonja Rudd in Wall Street News Alert's daily commentary continued at: http://www.WallStreetNewsAlert.com .

Let Wall Street News Alert help advertise for your company using our effective awareness campaigns. If you're interested in telling your story, we can help. Contact us at info@wallstreetnewsalert.com or see our services at http://www.wallstreetnewsalert.com/tPage.aspx?PAGE_TYPE=AU .

WSNA's email alert service is free to those investors who sign up on the WSNA home page. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. The Wall Street News Alert home page has experienced over 100 million hits. To subscribe to this free service, visit the Wall Street News Alert home page at http://www.wallstreetnewsalert.com and select the "join now" button.